FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098548617> ?p ?o ?g. }

• W2098548617 endingPage "5174" @default.
• W2098548617 startingPage "5167" @default.
• W2098548617 abstract "Abstract Purpose: Anaplastic gliomas constitute a heterogeneous group of tumors with different therapeutic responses to adjuvant chemotherapy with alkylating agents. O6-Methylguanine-DNA methyltransferase (MGMT), a DNA repair protein, is one of the implicated factors in glioma chemoresistance.The prognostic value of MGMT remains controversial due in part to the fact that previous published studies included heterogeneous groups of patients with different tumor grades. The aim of this study was to evaluate the prognostic significance of MGMT in patients with anaplastic glioma. Experimental Design: Ninety-three patients with anaplastic glioma were analyzed for MGMT protein expression by immunohistochemistry. In addition, for those patients from whom a good yield of DNA was obtained (n = 40), MGMT promoter methylation profile was analyzed by methylation-specific PCR. MGMT prognostic significance was evaluated together with other well-known prognostic factors. Results: Fifty-one tumors (54.8%) showed nuclear staining of MGMT. There was a trend towards longer overall survival for those patients with negative MGMT immunostaining (hazard ratio, 1.66; P = 0.066). In a secondary analysis including those patients who actually received chemotherapy (n = 72), the absence of MGMT expression was independently associated with better survival (hazard ratio, 2.12; P = 0.027). MGMT promoter methylation was observed in 50% of the analyzed tumors. No statistical correlation between MGMT expression and MGMT promoter hypermethylation was observed. Conclusions: Unlike previous studies, we did not find a correlation between MGMT promoter methylation and survival. However, we observed a correlation between MGMT protein expression and survival in those patients who received chemotherapy thus suggesting that the absence of MGMT expression is a positive predictive marker in patients with anaplastic glioma." @default.
• W2098548617 created "2016-06-24" @default.
• W2098548617 creator A5001416778 @default.
• W2098548617 creator A5007073802 @default.
• W2098548617 creator A5008091556 @default.
• W2098548617 creator A5014292559 @default.
• W2098548617 creator A5014342106 @default.
• W2098548617 creator A5033765620 @default.
• W2098548617 creator A5046643880 @default.
• W2098548617 creator A5060317246 @default.
• W2098548617 creator A5064532815 @default.
• W2098548617 creator A5066769147 @default.
• W2098548617 creator A5081762044 @default.
• W2098548617 creator A5089279712 @default.
• W2098548617 date "2005-07-15" @default.
• W2098548617 modified "2023-10-18" @default.
• W2098548617 title "Prognostic Significance of <i>O</i>6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas" @default.
• W2098548617 cites W111616551 @default.
• W2098548617 cites W1588444780 @default.
• W2098548617 cites W191043282 @default.
• W2098548617 cites W1918200890 @default.
• W2098548617 cites W1959628099 @default.
• W2098548617 cites W1986183552 @default.
• W2098548617 cites W1990911320 @default.
• W2098548617 cites W1993331812 @default.
• W2098548617 cites W1995570475 @default.
• W2098548617 cites W2000924030 @default.
• W2098548617 cites W2012260496 @default.
• W2098548617 cites W2016760158 @default.
• W2098548617 cites W2017985800 @default.
• W2098548617 cites W2019785099 @default.
• W2098548617 cites W2036085833 @default.
• W2098548617 cites W2039628166 @default.
• W2098548617 cites W2040257851 @default.
• W2098548617 cites W2044589341 @default.
• W2098548617 cites W2051711376 @default.
• W2098548617 cites W2053760880 @default.
• W2098548617 cites W2054823635 @default.
• W2098548617 cites W2057317344 @default.
• W2098548617 cites W2063547453 @default.
• W2098548617 cites W2074242592 @default.
• W2098548617 cites W2075895580 @default.
• W2098548617 cites W2078640192 @default.
• W2098548617 cites W2082657260 @default.
• W2098548617 cites W2084402855 @default.
• W2098548617 cites W2095999479 @default.
• W2098548617 cites W2098785952 @default.
• W2098548617 cites W2120872266 @default.
• W2098548617 cites W2121560055 @default.
• W2098548617 cites W2121749405 @default.
• W2098548617 cites W2139008103 @default.
• W2098548617 cites W2163995461 @default.
• W2098548617 cites W2168002000 @default.
• W2098548617 cites W2328547481 @default.
• W2098548617 cites W2328946792 @default.
• W2098548617 cites W4238295252 @default.
• W2098548617 doi "https://doi.org/10.1158/1078-0432.ccr-05-0230" @default.
• W2098548617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16033832" @default.
• W2098548617 hasPublicationYear "2005" @default.
• W2098548617 type Work @default.
• W2098548617 sameAs 2098548617 @default.
• W2098548617 citedByCount "176" @default.
• W2098548617 countsByYear W20985486172012 @default.
• W2098548617 countsByYear W20985486172013 @default.
• W2098548617 countsByYear W20985486172014 @default.
• W2098548617 countsByYear W20985486172015 @default.
• W2098548617 countsByYear W20985486172016 @default.
• W2098548617 countsByYear W20985486172017 @default.
• W2098548617 countsByYear W20985486172018 @default.
• W2098548617 countsByYear W20985486172019 @default.
• W2098548617 countsByYear W20985486172020 @default.
• W2098548617 countsByYear W20985486172021 @default.
• W2098548617 countsByYear W20985486172022 @default.
• W2098548617 countsByYear W20985486172023 @default.
• W2098548617 crossrefType "journal-article" @default.
• W2098548617 hasAuthorship W2098548617A5001416778 @default.
• W2098548617 hasAuthorship W2098548617A5007073802 @default.
• W2098548617 hasAuthorship W2098548617A5008091556 @default.
• W2098548617 hasAuthorship W2098548617A5014292559 @default.
• W2098548617 hasAuthorship W2098548617A5014342106 @default.
• W2098548617 hasAuthorship W2098548617A5033765620 @default.
• W2098548617 hasAuthorship W2098548617A5046643880 @default.
• W2098548617 hasAuthorship W2098548617A5060317246 @default.
• W2098548617 hasAuthorship W2098548617A5064532815 @default.
• W2098548617 hasAuthorship W2098548617A5066769147 @default.
• W2098548617 hasAuthorship W2098548617A5081762044 @default.
• W2098548617 hasAuthorship W2098548617A5089279712 @default.
• W2098548617 hasConcept C104317684 @default.
• W2098548617 hasConcept C126322002 @default.
• W2098548617 hasConcept C142724271 @default.
• W2098548617 hasConcept C143998085 @default.
• W2098548617 hasConcept C150194340 @default.
• W2098548617 hasConcept C190727270 @default.
• W2098548617 hasConcept C204232928 @default.
• W2098548617 hasConcept C207103383 @default.
• W2098548617 hasConcept C2776694085 @default.
• W2098548617 hasConcept C2777389519 @default.
• W2098548617 hasConcept C2778227246 @default.

• next